By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Next-Generation Sequencing (NGS) applications52.64M50.76%
DNA synthesis and protein solutions51.06M49.24%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States218.41M58.00%
EMEA124.24M32.99%
APAC26.75M7.10%
Americas7.17M1.90%